UNIVERSITY OF WASHINGTON

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1861-01-01

Employees: 10K

Market Cap: -

Website: https://www.cs.washington.edu

Clinical Trials

Higher or Lower Dose Cladribine, Cytarabine, and Mitoxantrone in Treating Medically Less Fit Patients With Newly Diagnosed Acute Myeloid Leukemia or Myeloid Neoplasm

Phase 2

Completed

Conditions: Acute Leukemia of Ambiguous Lineage
Myeloid Neoplasm
Acute Myeloid Leukemia

Interventions: Drug: Cladribine
Drug: Cytarabine
Biological: Granulocyte Colony-Stimulating Factor
Drug: Mitoxantrone Hydrochloride
Other: Quality-of-Life Assessment
Other: Questionnaire Administration

First Posted Date: 2017-01-06

Last Posted Date: 2022-03-08

Lead Sponsor: University of Washington

Target Recruit Count: 50

Registration Number: NCT03012672

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

CT Perfusion Images in Assessing Treatment Response in Patients With Pancreatic Cancer

Not Applicable

Terminated

Conditions: Pancreatic Ductal Adenocarcinoma

Interventions: Diagnostic Test: Computed Tomography Perfusion Imaging

First Posted Date: 2017-01-06

Last Posted Date: 2022-07-06

Lead Sponsor: University of Washington

Target Recruit Count: 70

Registration Number: NCT03012282

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

Diet as Essential Therapy (DIET) for Inflammatory Bowel Disease

Not Applicable

Conditions: Crohn Disease

Interventions: Dietary Supplement: Diet 1
Dietary Supplement: Diet 2

First Posted Date: 2017-01-06

Last Posted Date: 2018-05-17

Lead Sponsor: University of Washington

Target Recruit Count: 32

Registration Number: NCT03012542

Locations: 🇺🇸
University of Washington Medical Center, Seattle, Washington, United States

Effects of a Exercise Program on Health Outcomes in People With Diabetic Foot Ulcers

Not Applicable

Completed

Conditions: Diabetic Foot Ulcer
Diabetes Mellitus, Type 2

Interventions: Other: EnhanceFitness community exercise program

First Posted Date: 2016-12-23

Last Posted Date: 2022-10-06

Lead Sponsor: University of Washington

Target Recruit Count: 24

Registration Number: NCT03002155

Locations: 🇺🇸
Northwest Hospital, Seattle, Washington, United States

Podocyturia - Predictor of Renal Dysfunction in Fabry Nephropathy

Conditions: Fabry Disease

First Posted Date: 2016-12-15

Last Posted Date: 2017-08-28

Lead Sponsor: University of Washington

Target Recruit Count: 58

Registration Number: NCT02994303

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States
🇺🇸
Emory University, Decatur, Georgia, United States
🇺🇸
University of Minnesota, Minneapolis, Minnesota, United States

HIV Testing at Family Planning Clinics in Mombasa County, Kenya

Not Applicable

Completed

Conditions: HIV

Interventions: Other: Systems Analysis and Improvement Approach

First Posted Date: 2016-12-15

Last Posted Date: 2023-11-30

Lead Sponsor: University of Washington

Target Recruit Count: 24

Registration Number: NCT02994355

Locations: 🇰🇪
Junda, Mombasa, Kenya
🇰🇪
Junda Dispensary, Mombasa, Kenya
🇰🇪
Tudor, Mombasa, Kenya

and more 21 locations

Phase 1 Clinical Trial of Sodium Nitrite for Out of Hospital Cardiac Arrest

Phase 1

Completed

Conditions: Out-Of-Hospital Cardiac Arrest

First Posted Date: 2016-12-08

Last Posted Date: 2018-05-07

Lead Sponsor: University of Washington

Target Recruit Count: 120

Registration Number: NCT02987088

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

Expanded Access With ABT-888 (Veliparib) to Treat Metastatic Breast Cancer

Conditions: Metastatic Breast Cancer With BRCA 1 or BRCA 2 Genetic Mutation
Triple-Negative Breast Cancer

First Posted Date: 2016-12-07

Last Posted Date: 2021-07-21

Lead Sponsor: University of Washington

Registration Number: NCT02985658

Locations: 🇺🇸
Seattle Cancer Care Allliance, Seattle, Washington, United States

Remote Supervision for Implementing Collaborative Care for Perinatal Depression

Not Applicable

Conditions: Perinatal Depression

Interventions: Other: Longitudinal Remote Consultation
Other: Collaborative Care

First Posted Date: 2016-11-29

Last Posted Date: 2021-04-28

Lead Sponsor: University of Washington

Target Recruit Count: 20

Registration Number: NCT02976025

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

Durvalumab in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

Phase 2

Withdrawn

Conditions: Hormone-Resistant Prostate Cancer
Castration Levels of Testosterone
Microsatellite Instability

Interventions: Biological: Durvalumab
Other: Laboratory Biomarker Analysis

First Posted Date: 2016-11-17

Last Posted Date: 2018-01-17

Lead Sponsor: University of Washington

Registration Number: NCT02966587

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy